RAIN THERAPEUTICS INC's ticker is RAIN and the CUSIP is 75082Q105. A total of 47 filers reported holding RAIN THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $11,703,001 | +14.3% | 1,336,722 | +4.1% | 0.01% | +14.3% |
| Q4 2022 | $10,242,378 | +162.6% | 1,283,506 | -20.7% | 0.01% | +133.3% |
| Q3 2022 | $3,899,896 | -4.4% | 1,618,208 | +120.9% | 0.00% | 0.0% |
| Q2 2022 | $4,080,000 | +26.6% | 732,655 | +15.1% | 0.00% | +50.0% |
| Q1 2022 | $3,223,000 | -79.7% | 636,768 | -48.2% | 0.00% | -71.4% |
| Q4 2021 | $15,841,000 | -22.6% | 1,230,455 | -12.2% | 0.01% | -22.2% |
| Q3 2021 | $20,455,000 | -4.8% | 1,402,074 | -3.5% | 0.01% | 0.0% |
| Q2 2021 | $21,491,000 | – | 1,452,615 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,560,652 | $7,616,000 | 1.78% |
| Cormorant Asset Management, LP | 2,326,660 | $11,354,000 | 0.79% |
| BVF INC/IL | 3,526,729 | $17,210,000 | 0.71% |
| Perceptive Advisors | 2,483,619 | $12,120,000 | 0.35% |
| Boxer Capital, LLC | 1,175,000 | $5,734,000 | 0.32% |
| UBS OCONNOR LLC | 326,451 | $1,593,000,000 | 0.03% |
| Ergoteles LLC | 65,096 | $318,000 | 0.01% |
| Lumina Fund Management LLC | 6,000 | $29,000 | 0.01% |
| Laurion Capital Management LP | 313,200 | $1,528,000 | 0.01% |
| Woodline Partners LP | 119,700 | $584,000 | 0.01% |